---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-099253"
form_type: "8-K"
ticker: "RIBB"
cik: "0002035016"
company_name: "Ribbon Acquisition Corp."
filed_at: "2026-09-11T20:03:12+00:00"
generated_at: "2026-09-11T20:04:12.148924+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Ribbon Acquisition shareholders approve DRC Medicine deal; heavy redemptions leave $1.4M trust

## Summary
- All 8 proposals passed, including Business Combination with DRC Medicine Ltd. (2,835,534 for, 371,112 against).
- Domestication to Delaware approved; also Charter NTA amendment, Nasdaq issuance, Incentive Plan, director elections.
- Redemptions: 3,460,471 shares tendered; after 30,633 reversals, 3,429,838 remain subject to redemption (~$36,321,984.42).
- Trust account balance after redemptions ~$1,411,594.05; per-share redemption price ~$10.59.
- Seven Pubco directors elected, including Narumi Okazaki, Akira Okada, Shigeo Kamitsuji, etc.

## SEC filing metadata
- accession: 0001213900-26-099253
- form_type: 8-K
- ticker: RIBB
- cik: 0002035016
- company_name: Ribbon Acquisition Corp.
- filed_at: 2026-09-11T20:03:12+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2035016/000121390026099253/0001213900-26-099253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2035016/000121390026099253/ea0305127-8k_ribbon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-099253
- JSON: https://secwatch.observer/filing/0001213900-26-099253.json
- Plain text: https://secwatch.observer/filing/0001213900-26-099253.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.